Literature DB >> 18033970

Pediatric obstructive sleep apnea: current management.

Zoukaa Sargi1, Ramzi T Younis.   

Abstract

Obstructive sleep apnea syndrome (OSAS) is a condition frequently encountered in children, and belongs to a spectrum of diseases called sleep-disordered breathing. Its pathophysiology is related to decreased ventilation despite respiratory effort, leading to episodes of hypopnea and apnea. Left untreated, this condition could have a significant impact on both physical and mental health. Primary snoring is often the presenting symptom reported by parents, and should warrant careful screening for OSAS. Although overnight polysomnography remains the gold standard diagnostic test for OSAS, its feasibility in clinical practice is less obvious, and furthermore, interpretation of its results is not unanimously agreed on. This is why in clinical practice history and physical examination remain among the most useful diagnostic tools. Management of OSAS traditionally includes tonsillectomy and/or adenoidectomy to which most of the cases respond. However, other risk factors and coexisting conditions should be carefully investigated and treated prior to considering surgical treatment. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18033970     DOI: 10.1159/000108365

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  3 in total

1.  Effectiveness of the analysis of craniofacial morphology and pharyngeal airway morphology in the treatment of children with obstructive sleep apnoea syndrome.

Authors:  K Sato; T Shirakawa; H Sakata; S Asanuma
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

Review 2.  Indications for tonsillectomy stratified by the level of evidence.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

Review 3.  Treatment alternatives for sleep-disordered breathing in the pediatric population.

Authors:  Ann C Halbower; Brian M McGinley; Philip L Smith
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.